期刊文献+

聚乙二醇干扰素联合利巴韦林治疗慢性丙肝的护理要点探讨 被引量:3

Discussion of Polyethylene Glycol(peg) Interferon Plus Ribavirin Treatment of Chronic Hepatitis c Nursing
在线阅读 下载PDF
导出
摘要 目的:探讨聚乙二醇干扰素联合利巴韦林治疗慢性丙肝的护理要点。方法选取2013年2月~2014年2月于我院就诊的32例慢性丙肝患者作为本次研究的对象,所有患者均采用聚乙二醇干扰素联合利巴韦林治疗,护理措施主要有心理护理、消化道症状护理、感冒症状护理、白细胞降低护理、脱发护理以及出院护理等。结果所有患者均完成全程治疗,通过护理缓解了痛苦,加快患者恢复。结论对慢性丙肝患者实施有效的护理干预,是保障治疗成功的关键。 Objective To investigate the pegylated interferon plus ribavirin (nursing key points of the treatment of chronic hepatitis c. Methods Selected in February 2013 to February 2013 in our hospital of 32 cases of chronic hepatitis c patients as the research object, all patients were using polyethylene glycol (peg) interferon plus ribavirin treatment, nursing measures mainly include psychological care, gastrointestinal symptoms, cold symptoms nursing, white blood cells reduce hospital care, hair care and nursing, etc. Results All patients underwent treatment all the way, through nursing to alleviate the pain, to speed up the patients recovery. Conclusion Effective nursing intervention in patients with chronic hepatitis c, is the key to ensure successful treatment.
出处 《中国继续医学教育》 2015年第9期109-110,共2页 China Continuing Medical Education
关键词 聚乙二醇干扰素 利巴韦林 慢性丙肝 护理 Polyethylene glycol interferon Ribavirin Chronic hepatitis c Nursing
  • 相关文献

二级参考文献28

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2徐道振,谢尧,陆志檬,骆抗先,贾继东,王宇明,赵桂珍,张树林,张大志.聚乙二醇干扰素α-2a与干扰素α-2a治疗慢性丙型肝炎疗效、安全性的评估[J].中华传染病杂志,2004,22(4):221-224. 被引量:37
  • 3Reedy KR,Wright TL,Pockros PJ,et al.Efficacy and safety of pegylated (40-kd) interfreon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C[J]Hepatology,2001,33:433-438.
  • 4Strader DB,Wright T,Thomas DL,et al.ASSLD practice guideline:Diagnosis,management,and treatment of hepatitis C[J].Hepatology,2004,39:1147-1171.
  • 5Dieterich DT,Wasserman R,Brau N,et al.Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa[J].American Journal of Gastroenterology,2003:98,2491-2499.
  • 6Fried M,Shiffman M,Reddy K,et al.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J].New England Journal of Medicine,2002:347,975-982.
  • 7焦健,王江滨.丙型肝炎抗病毒治疗中的常见问题[J].临床肝胆病杂志,2007,23(4):304-306. 被引量:5
  • 8李卫国,王合群,赵磊,赵皓,周雍军,石贵福.慢性丙型肝炎疗效观察[J].中原医刊,2007,34(15):53-54. 被引量:1
  • 9Fattovich G,Giustina G,Degos F,et al.Morbidity and mortality in compensated cirrhosis type C:A retrospective follow-up study of 384 patients[J].Gastroenterology,1997(112):463-472.
  • 10Zeuzem S,Welsch C,Herrmann E.Pharmacokineties of peginter-ferons[J].Semin Liver Dis,2003,23(Suppl 1):23-28.

共引文献44

同被引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部